LAR · Lithium Argentina AG

Current Thesis

LAR is the highest-beta liquid proxy on the 2026 lithium-price recovery, and that recovery has now rolled over. China battery-grade carbonate fell to CNY 163,000/t on 2026-06-05 (TradingEconomics), down 3.12% on the day and -18.7% from the two-year high of CNY 200,500 printed 2026-05-13 a roughly three-week, ~19% reversal. The reason is textbook commodity mechanics: the run to two-year highs pulled idled supply back online (Mineral Resources restarting Bald Hill after an 18-month suspension; Core Lithium restarting Finniss) while record carbonate warehouse warrants on the Guangzhou Futures Exchange flagged bloated inventory. The remaining bull leg is mechanical, not directional: LAR's Q1 2026 realized price was only ~$16,818/t against ~$25k spot because contracts price on a quarter lag, so the Q2 report (~2026-08-12) should still show a realized step-up toward the elevated April–May average. That print is largely baked. What is broken is the forward momentum that drove the stock 5.8x off its 2025 low Q3 realized will reflect a falling tape, and a high-beta commodity proxy sitting at/above its Street price targets with the underlying in a clear downtrend is not a momentum setup. Stance: stand aside until spot stabilizes into a floor or the stock re-bases; a fresh chase here has no edge.

Bull Case

• Operating leverage is real and proven. Q1 2026 adjusted EBITDA tripled to ~$106M (from ~$30M prior quarter); cash operating cost $5,391/t (Q1 6-K / transcript, 2026-05-12). Bottom-quartile brine cost means margin still expands hard on any realized-price increase.
• Q2 realized catch-up is largely mechanical. Q1 realized $16,818/t lagged ~$25k spot by ~33%. With April–May spot averaging well above Q1, the Q2 report (~2026-08-12) should show a realized step-up even though spot has since fallen a structurally embedded earnings tailwind already in the pipe.
• Lowest-cost tier endures a downturn. Cauchari-Olaroz ran ~97% of design two consecutive quarters; Q1 2026 output 9,660t; 2026 guide reiterated at 35,000–40,000t; company expects to convert >90% of Q1 EBITDA to cash in 2026.
• Analyst re-rating still tracking higher. Deutsche Bank lifted PT to $12 from $11 (Buy, 2026-05-13); Scotiabank to $11 from $8.50 (Outperform, top small-cap pick, 2026-05-15). Street range ~$11–$21.
• Special-sits overlay intact. Ganfeng will hold 67% of the consolidated PPG JV (Pastos Grandes + Sal de la Puna + Pozuelos, Aug-2025 framework) and extended a 6-yr $130M facility at SOFR+2.5% (2026-03-20). As Cauchari-Olaroz partner, lender, and majority PPG holder, Ganfeng deepening control keeps full-consolidation/takeout speculation alive.

Bear Case

• The commodity is in an active downtrend. China carbonate CNY 163,000/t on 2026-06-05, -3.12% daily, -13.07% MoM, -18.7% off the 2026-05-13 high. A commodity-momentum trade with the underlying making lower highs and lower lows is on the wrong side of the tape.
• Supply is responding to price the mean-reversion trigger. Bald Hill (MinRes) and Finniss (Core Lithium) restarts plus record GFEX warrants point to a 2026 surplus dynamic, consistent with S&P Global's "narrowing surplus, not deficit" framing.
• Extended, high-beta, mean-reversion-prone. ~$10.80 (2026-06-03) is ~5.8x off the 2025-06-03 low of $1.71; beta 2.53, ~5.7% daily vol. A high-beta proxy typically follows the commodity down with amplification once the tape rolls.
• Price already at/above the Street. ~$10.80 stock vs Scotia $11 / DB $12 PTs near-term analyst headroom is thin; the stock needs spot to re-accelerate, and spot is doing the opposite.
• Catalyst vacuum for the thesis. The only dated event inside 30 days is the 2026-06-19 AGM, a governance vote (2025 results, equity plan) with no fundamental read-through. The earnings catalyst is ~2026-08-12, outside the window.
• Single-asset, single-country. One producing brine operation in Argentina; exposure to peso/RIGI/permitting and to Ganfeng minority-squeeze risk as the partner tightens its grip.

Setup & Price Structure

Last ~$10.80 (2026-06-03 range $10.22–$10.91), market cap ~$1.78B. The stock is holding near its highs even as China carbonate has dropped ~19% off the May-13 peak a divergence that, for a 2.53-beta commodity proxy, usually resolves toward the commodity rather than away from it. Price sits at/above both fresh Street PTs ($11 Scotia, $12 DB), so the marginal buyer is paying up with limited analyst cover above. The relevant structural floor is the ~$8.00–$9.00 breakout-retest shelf from the spring advance; a weekly close that loses ~$8.00 would break the uptrend that has defined the move. There is no clean pullback-to-support entry on offer here the name is extended into a weakening commodity, which is a wait-for-re-base condition, not a buy condition.

Catalyst Calendar (next 30 days)

• 2026-06-19 Annual General Meeting (Zug, Switzerland + Sun Valley, Idaho). Governance vote on 2025 results, board, and equity plan. Low impact; not a thesis catalyst do not size to it.
• Daily China carbonate / spodumene spot prints the actual driver. Watch whether CNY 163,000/t holds or continues lower; reclaim of CNY 180,000+ with a higher high would re-open the bull leg.
• ~2026-08-12 (est.) Q2 2026 earnings (OUTSIDE 30d). The mechanical realized-price catch-up print.
• H1 2026 PPG feasibility study + RIGI application / New JV close (no fixed date). Special-sits optionality on the Ganfeng consolidation; a dated close would be a fresh catalyst.

What Would Change Our Mind

• Re-accelerate (back to constructive): China carbonate reclaims ~CNY 180,000/t and prints a higher high while restart supply stalls; LAR holds the ~$8–$9 shelf and breaks to a new high on volume a stabilize-then-resume structure rather than a falling-knife chase.
• Confirm broken (full exit / avoid): carbonate holding below ~CNY 130,000/t (~$18,000/t) that kills the Q2/Q3 realized catch-up; a weekly close below the ~$8.00 breakout-retest shelf; or Cauchari-Olaroz 2026 output tracking under the 35,000t low end of guide, which removes the volume offset to falling price.
• Special-sits surprise: a Ganfeng move to full-consolidate Cauchari-Olaroz or take out the minority would re-rate the name independent of the lithium tape a reason to revisit even in a weak commodity.

Correlation Notes

LAR trades as a leveraged derivative of China lithium carbonate and spodumene spot the primary correlation is to the GFEX/SMM lithium complex, not to broad equity or AI baskets, so it is a poor diversifier inside a momentum-tech book and a clean way to express a lithium view. Tight co-movement with ALB, SQM, and Ganfeng; sensitivity to China battery/EV/ESS demand prints and to any further mine restarts. Idiosyncratic overlay from Argentina country risk (peso, RIGI incentive regime, permitting) and from Ganfeng's triple role as JV partner, lender, and 67% PPG owner, which adds consolidation/squeeze optionality uncorrelated to the commodity. Beta 2.53 means moves in either direction are amplified versus the underlying carbonate price.